Latest filing published 15 May 2026 for Karyopharm Therapeutics Inc., €2,639. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Sohanya Roshan Cheng in Karyopharm Therapeutics Inc. We count 19 filings; the first trade dates from 30 June 2021 and the latest from 14 May 2026.
Every open-market trade on record is a sale: 8 sales worth €101k. The rest of the record consists of 11 share grants. In 2026 alone, the filings show no purchases and 2 sales.
Most recently, on 15 May 2026, the filings show an open-market sale worth €2,639 in Karyopharm Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations